REMUS logo

Remus Pharmaceuticals Limited Stock Price

NSEI:REMUS Community·₹7.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

REMUS Share Price Performance

₹629.95
-448.17 (-41.57%)
₹629.95
-448.17 (-41.57%)
Price ₹629.95

REMUS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
2 Rewards

Remus Pharmaceuticals Limited Key Details

₹7.5b

Revenue

₹6.5b

Cost of Revenue

₹969.1m

Gross Profit

₹634.0m

Other Expenses

₹335.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
28.74
12.96%
4.48%
4.2%
View Full Analysis

About REMUS

Founded
2015
Employees
68
CEO
Arpit Shah
WebsiteView website
remuspharma.com

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceuticals products and allied products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical and consultancy services to various distributors and contract manufacturing services. The company offers tablet, hard and soft gelatine capsules, liquid and lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays and solutions, eye drops, creams, gels, ointments, suspensions, oral solutions and suspensions, sachets, and ophthalmic and other dosage forms. It also exports its products. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Recent REMUS News & Updates

There Are Reasons To Feel Uneasy About Remus Pharmaceuticals' (NSE:REMUS) Returns On Capital

Feb 11
There Are Reasons To Feel Uneasy About Remus Pharmaceuticals' (NSE:REMUS) Returns On Capital

Recent updates

No updates